We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+6.79%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+553.89%
AUM
$156M
AUM Growth
+$2.02M
Cap. Flow
-$6.08M
Cap. Flow %
-3.89%
Top 10 Hldgs %
32.73%
Holding
104
New
14
Increased
29
Reduced
42
Closed
12

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$1.51M
2
EPD icon
Enterprise Products Partners
EPD
+$1.2M
3
DHR icon
Danaher
DHR
+$1.05M
4
FTV icon
Fortive
FTV
+$987K
5
AAPL icon
Apple
AAPL
+$701K

Top Sells

Rank Stock Value
1
ETN icon
Eaton
ETN
+$3.09M
2
HCA icon
HCA Healthcare
HCA
+$2.86M
3
MSFT icon
Microsoft
MSFT
+$920K
4
RCMT icon
RCM Technologies
RCMT
+$778K
5
BIIB icon
Biogen
BIIB
+$638K

Sector Composition

Rank Sector Weight
1 Healthcare 19.57%
2 Technology 18.31%
3 Financials 17.57%
4 Energy 12.04%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
76
RTX Corp
RTX
$289B
$258K 0.17%
4,030
+57
+1% +$3.78K
BZQ icon
77
ProShares UltraShort MSCI Brazil Capped
BZQ
$2.35M
$250K 0.16%
+156
New +$270K
CY
78
DELISTED
Cypress Semiconductor
CY
$243K 0.16%
+20,000
New +$229K
AR icon
79
Antero Resources
AR
$10.9B
$225K 0.14%
+8,353
New +$222K
TENX icon
80
Tenax Therapeutics
TENX
$401M
$218K 0.14%
3
+1
+50% +$78.9K
SGMO
81
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$211K 0.14%
45,500
-3,500
-7% -$17.8K
TIF
82
DELISTED
Tiffany & Co.
TIF
$210K 0.13%
+2,898
New +$193K
GTLS
83
DELISTED
Chart Industries
GTLS
$201K 0.13%
+6,110
New +$177K
ACHN
84
DELISTED
Achillion Pharmaceuticals
ACHN
$174K 0.11%
21,500
-9,000
-30% -$76.5K
BLDR icon
85
Builders FirstSource
BLDR
$7.1B
$173K 0.11%
+15,000
New +$189K
RGLS
86
DELISTED
Regulus Therapeutics
RGLS
$149K 0.1%
377
-212
-36% -$87.2K
CPN
87
DELISTED
Calpine Corporation
CPN
$126K 0.08%
+10,000
New +$135K
DRNA
88
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$94K 0.06%
16,000
-4,000
-20% -$14K
MBOT icon
89
Microbot Medical
MBOT
$117M
$93K 0.06%
505
+166
+49% +$21.7K
SPWR
90
DELISTED
SunPower Corporation Common Stock
SPWR
$89K 0.06%
+15,270
New +$119K
SPHS
91
DELISTED
Sophiris Bio, Inc.
SPHS
$31K 0.02%
+10,000
New +$37.6K
RBCN
92
DELISTED
Rubicon Technology, Inc.
RBCN
$25K 0.02%
+3,932
New +$25.1K
BAC icon
93
Bank of America
BAC
$433B
-19,252
Closed -$255K
CHRS icon
94
Coherus Oncology
CHRS
$227M
-13,400
Closed -$226K
ETN icon
95
Eaton
ETN
$150B
-51,775
Closed -$3.09M
B
96
Barrick Mining
B
$63.2B
-10,000
Closed -$213K
GRPN icon
97
Groupon
GRPN
$1.06B
-1,500
Closed -$97K
HCA icon
98
HCA Healthcare
HCA
$85.7B
-37,150
Closed -$2.86M
HUN icon
99
Huntsman Corp
HUN
$2.12B
-15,000
Closed -$202K
ODP
100
DELISTED
ODP
ODP
-4,000
Closed -$132K

Similar funds

Bourgeon Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Bourgeon Capital Management held 104 positions worth $156M, up 1.3% from $154M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bourgeon Capital Management withdrew a net $6.08M in Q3 2016, closing 12 positions and reducing 42 holdings. Its most notable exit was Eaton, an estimated $3.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Bourgeon Capital Management opened a new position in Fortive worth $987K.

  • Bourgeon Capital Management's largest Q3 2016 buy was Fortive: 30,764 shares worth $987K.
  • Bourgeon Capital Management added most to Nike in Q3 2016, an estimated $1.51M increase.
  • Bourgeon Capital Management's biggest Q3 2016 reduction was Microsoft, cutting an estimated $920K.
  • Bourgeon Capital Management fully exited Eaton in Q3 2016, selling an estimated $3.09M.
  • Bourgeon Capital Management's ten largest holdings make up 33% of its $156M portfolio in Q3 2016.
  • Bourgeon Capital Management opened 14 new positions and closed 12 in Q3 2016.
  • Bourgeon Capital Management's portfolio value rose 1.3% quarter-over-quarter to $156M.

Based on Bourgeon Capital Management's 13F filing for Q3 2016, filed 26 Oct 2016.